Lectures and seminars Seminar with Dr. Gregory K. Brown: Clinical Interventions for Individuals at Risk of Suicide
The National centre for suicide research and prevention (NASP) invites you to a seminar with Dr. Gregory K. Brown, an internationally renowned expert in suicide prevention. Dr. Brown will present his work on clinical interventions for individuals at risk for suicide with particular focus on safety planning.
Dr. Brown is the developer, along with his colleagues, of two clinical interventions for individuals at risk for suicide including the The Stanley-Brown Safety Planning Intervention and Cognitive Therapy for Suicide Prevention. The Safety Planning Intervention is an evidence-based, brief suicide prevention strategy that has been used in research and widely disseminated in health care settings, including the Veterans Health Administration (VHA). He also developed one of the few existing evidence-based psychotherapy interventions, Cognitive Therapy for Suicide Prevention, which has been shown to prevent suicide attempts among individuals at high risk for suicide.
In this seminar Dr. Brown will give us a presentation about clinical interventions for individuals at risk for suicide with particular focus on safety planning. There will also be time for discussion.
Target Audience
This seminar is intended for researchers, clinicians, students, and professionals working in the fields of psychology, psychiatry, and suicide prevention. Anyone with an interest in evidence-based approaches to mental health and suicide risk reduction is welcome to attend.
Language
The seminar will be held in English.
Register
Please register before 20th of October using the link below. Space is limited and registration mandatory.
Dr. Gregory K. Brown
Dr. Brown is an internationally renowned expert in suicide prevention whose work has led to transformational advances in the treatment of suicidal individuals. His research aims to develop and evaluate the effectiveness of innovative, targeted interventions designed to reduce vulnerability factors associated with suicide behaviour in high-risk populations and to examine and improve the implementation of evidence-based treatments into “real world” settings to prevent suicide.